Search For "kiran mazumdar shaw"
Mapmygenome launches Genomics Experience Center in Bengaluru
Updated : 4 years ago IST
Bengaluru (Karnataka) [India], March 2 (ANI/PR Newswire): Mapmygenome India opened its Genomics Experience Center in Bengaluru on March 1. The NABL & ICMR certified center is located at Sector 7, HSR Layout. The new center is an expansion of Mapmygenome's services provided in Hyderabad a
Read More
Biocon Biologics to acquire Viatris' Biosimilars Assets for up to USD 3.33
Updated : 4 years ago IST
Bengaluru (Karnataka) [India], March 1 (ANI/PR Newswire): Biocon Biologics Ltd, a subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASDAQ: VTRS). Accordingly, Biocon Biologics Ltd (BBL) will acquire Viatris'
Read More
Narayana Health in association with Goldman Sachs sets up a new 100-bed CO
Updated : 4 years ago IST
Bengaluru (Karnataka) [India], February 14 (ANI/NewsVoir): Narayana Health, a leading healthcare provider in the country, today announced that they have expanded their COVID ICU facilities.
Read More
Bugworks Research Inc. secures US$18M Series B1 Funding from Reputed Globa
Updated : 4 years, 1 month ago IST
Bengaluru (Karnataka) [India]/ Saratoga (California) [US]/ Adelaide [Australia], February 9 (ANI/PRNewswire): Bugworks Research, a clinical stage multi-indication therapeutics company, today announced the financing of US$18M Series B1.
Read More
Union Budget 2022-23: Industry experts welcome govt's focus on healthcare
Updated : 4 years, 1 month ago IST
New Delhi [India], February 1 (ANI): Welcoming the Union Budget for FY 2022-23, industry experts said the government's renewed focus on healthcare will build stronger health systems in the country.
Read More
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Updated : 4 years, 5 months ago IST
Bengaluru (Karnataka) [India], Sep 17 (ANI): Biocon Biologics Ltd (BBL) and Serum Institute Life Sciences (SILS) have announced a strategic alliance in a bid to make a significant impact on global healthcare through vaccines and biologics.
Read More
Biocon posts Rs 257 crore profit for Q4 on strong biosimilar business
Updated : 4 years, 10 months ago IST
Bengaluru (Karnataka) [India], April 29 (ANI): Biopharmaceuticals major Biocon Ltd on Thursday reported net profit of Rs 257 crore in the fourth quarter of FY21, up 95 per cent from Rs 132 crore in Q4 FY20.
Read More
Biocon reports 17 pc dip in Q3 net profit at Rs 169 cr
Updated : 5 years, 1 month ago IST
Bengaluru (Karnataka) [India], January 22 (ANI): Biopharmaceuticals major Biocon Ltd has reported 17 per cent decline in its net profit to Rs 169 crore during the quarter ended December while the company's topline grew by 7 per cent to Rs 1,879 crore.
Read More
Biocon Biologics gets Rs 555 crore capital injection from ADQ
Updated : 5 years, 2 months ago IST
Bengaluru (Karnataka) [India], Jan 7 (ANI): Abu Dhabi-based ADQ will invest Rs 555 crore for 1.8 per cent minority stake in Biocon Biologics, valuing it at a post money valuation of 4.17 billion dollars (about Rs 30,482 crore).
Read More
HCL's Roshni Nadar Malhotra tops Kotak Wealth-Hurun's list of 'Leading Wea
Updated : 5 years, 3 months ago IST
New Delhi [India], December 3 (ANI): HCL Technologies' Roshni Nadar Malhotra was declared the wealthiest businesswoman in India followed by Biocon's Kiran Mazumdar-Shaw and USV's Leena Gandhi Tewari by the 'Kotak Wealth Hurun - Leading Wealthy Women' - a compilation of the wealthiest women i
Read More
New insulin glargine injection launched in US for diabetes patients
Updated : 5 years, 6 months ago IST
Bengaluru (Karnataka) [India], Aug 31 (ANI): Biocon Biologics and Mylan on Monday announced the US launch of Semglee™ (insulin glargine injection) in vial and pre-filled pen presentations, approved to help control high blood sugar in adult and paediatric patients with type 1 diabetes a
Read More
Tata Capital to pick minority stake in Biocon Biologics for Rs 225 cr
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], July 31 (ANI): Private equity major Tata Capital Growth Fund will pick up 0.85 per cent stake in the biologics arm of biopharmaceutical major Biocon for Rs 225 crore.
Read More